Skip to content
Screener

Accrued Expenses at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$862.4M+3.2%
IQVIA logo
IQVIAIQV
$457M-25.4%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$380.8M0.0%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$14.88M+19.4%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$14.11M
NeoGenomics logo
NeoGenomicsNEO
$56.27M+15.9%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.1%
Enterprise value$16.05B+31.0%
P/E33.4×+4.3×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
Line itemAs of / June 30,2026As of / December 31,2025
Employee compensation and benefits$79,428$80,139
Project related reimbursable expenses356,929316,013
Other14,71912,230
Total accrued expenses$451,076$408,382

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s accrued expenses?
Medpace Holdings, Inc. (MEDP) reported accrued expenses of $79.43M in Q2 2026.
How has Medpace Holdings, Inc.'s accrued expenses changed year-over-year?
Medpace Holdings, Inc.'s accrued expenses increased by 16.4% year-over-year, from $68.24M to $79.43M.
What is the long-term trend for Medpace Holdings, Inc.'s accrued expenses?
Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s accrued expenses has grown at a 27.8% compound annual growth rate (CAGR), from $23.53M to $80.14M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Medpace Holdings, Inc.'s accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude